Table 1.

Reduction in incidence and prevalence of COVID-19 cases (January 2020–April 2020) in comparison to the frequency of various malignancies during Pre-COVID-19 time (January 2019–April 2019) in a study by London et al. [12].

Type of cancer		Reduction in Prevalence of cancer cases	Reduction in Incidence of cancer cases
1.	Melanoma,	−51.8%, and	−67.1%
2.	Prostate cancer,	−49.1%,	−46.8%
3.	Breast cancer	−47.7%	−50.5%,
4.	Lung cancer	−39.1%	−46.8%;
5.	Hematologic cancers	−39.1%	−54.2%
6.	Colorectal cancer	−39.9%	−54.2%

(From: London et al. JCO Clin Cancer Inform. 2020).